And Abiomed has the inside track on understanding exactly how these pumps are being used and how that clinical workflow is best managed to get the best outcomes for those patients.

Source: https://seekingalpha.com/article/4633757-johnson-and-johnson-jnj-2023-wells-fargo-securities-healthcare-conference-transcript?source=feed_all_articles

In other Abiomed news, VP Matthew T. Plano sold 3,544 shares of Abiomed stock in a transaction dated Tuesday, November 1st.

Source: https://www.americanbankingnews.com/2023/01/13/abiomed-inc-nasdaqabmd-shares-purchased-by-new-york-state-teachers-retirement-system.html

In other Abiomed news, VP Matthew T. Plano sold 3,544 shares of Abiomed stock in a transaction dated Tuesday, November 1st.

Source: https://www.americanbankingnews.com/2023/01/13/abiomed-inc-nasdaqabmd-shares-purchased-by-new-york-state-teachers-retirement-system.html

The Interventional Solutions franchise delivered operational growth of 56.9%, which includes $331 million related to Abiomed.

Source: https://www.marketscreener.com/quote/stock/JOHNSON-JOHNSON-4832/news/Johnson-Johnson-JNJ-Q2-2023-Transcript-Final-44394180/?utm_medium=RSS&utm_content=20230721